MedTech Strategist, the global medical device industry's most trusted resource, will help you stay ahead of the opportunities and obstacles that are impacting your corporate strategy. We invite you to explore our coverage. Think Strategically. Subscribe Today
Browse Latest Issue
In the ALLEVIATE-HF clinical trial, continuous monitoring provided by Medtronic’s insertable cardiac monitor revealed a substantial burden of previously unsuspected arrhythmias in patients with both HFrEF and HFpEF—many of whom would not ordinarily qualify for an implantable cardiac device.
Despite geopolitical challenges and fierce competition for capital, the medtech investment market has maintained the momentum from 2025 through 2026, according to PwC’s latest medtech deals outlook.
Despite geopolitical challenges and fierce competition for capital, the medtech investment market has maintained the momentum from 2025 through 2026, according to PwC’s latest medtech deals outlook.